FinTrust Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $287K | Sell |
3,424
-1,000
| -23% | -$83.8K | 0.05% | 255 |
|
|
2024
Q2 | $341K | Buy |
4,424
+71
| +2% | +$5.47K | 0.06% | 211 |
|
|
2024
Q1 | $298K | Sell |
4,353
-835
| -16% | -$57.2K | 0.06% | 227 |
|
|
2023
Q4 | $300K | Hold |
5,188
| – | – | 0.06% | 225 |
|
|
2023
Q3 | $274K | Sell |
5,188
-34,468
| -87% | -$1.82M | 0.06% | 222 |
|
|
2023
Q2 | $1.83M | Hold |
39,656
| – | – | 0.44% | 54 |
|
|
2023
Q1 | $1.83M | Hold |
39,656
| – | – | 0.44% | 55 |
|
|
2022
Q4 | $1.83M | Sell |
39,656
-3,377
| -8% | -$156K | 0.44% | 55 |
|
|
2022
Q3 | $1.77M | Buy |
43,033
+584
| +1% | +$24K | 0.46% | 49 |
|
|
2022
Q2 | $1.62M | Sell |
42,449
-877
| -2% | -$33.4K | 0.4% | 59 |
|
|
2022
Q1 | $1.92M | Buy |
43,326
+8,032
| +23% | +$356K | 0.44% | 51 |
|
|
2021
Q4 | $1.5M | Sell |
35,294
-875
| -2% | -$37.2K | 0.36% | 62 |
|
|
2021
Q3 | $1.57M | Buy |
36,169
+2,193
| +6% | +$95.1K | 0.41% | 58 |
|
|
2021
Q2 | $1.45M | Buy |
+33,976
| New | +$1.45M | 0.38% | 64 |
|
|
2020
Q4 | – | Sell |
-157
| Closed | -$6 | – | 1067 |
|
|
2020
Q3 | $6 | Hold |
157
| – | – | ﹤0.01% | 912 |
|
|
2020
Q2 | $6K | Sell |
157
-100
| -39% | -$3.82K | ﹤0.01% | 794 |
|
|
2020
Q1 | $8K | Sell |
257
-100
| -28% | -$3.11K | ﹤0.01% | 779 |
|
|
2019
Q4 | $16K | Buy |
357
+119
| +50% | +$5.33K | 0.01% | 670 |
|
|
2019
Q3 | $10K | Sell |
238
-126
| -35% | -$5.29K | ﹤0.01% | 729 |
|
|
2019
Q2 | $16K | Sell |
364
-414
| -53% | -$18.2K | 0.01% | 638 |
|
|
2019
Q1 | $30K | Sell |
778
-2,500
| -76% | -$96.4K | 0.01% | 493 |
|
|
2018
Q4 | $115K | Buy |
+3,278
| New | +$115K | 0.06% | 244 |
|